Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP510313.RAGqlGGqmXWS0n8vVnxEiwLN7h1Gj8vQIo4n4tRlUxE9E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP510313.RAGqlGGqmXWS0n8vVnxEiwLN7h1Gj8vQIo4n4tRlUxE9E130_assertion type Assertion NP510313.RAGqlGGqmXWS0n8vVnxEiwLN7h1Gj8vQIo4n4tRlUxE9E130_head.
- NP510313.RAGqlGGqmXWS0n8vVnxEiwLN7h1Gj8vQIo4n4tRlUxE9E130_assertion description "[Compared with double noncarriers (angiotensinogen -20aa and ACE II), double heterozygotes (ac-I/D genotype), and double homozygotes (cc-DD) had hazard ratios for atrial fibrillation of 1.2(0.9-1.6; P=0.06) and 2.4(1.4-4.1; P=0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP510313.RAGqlGGqmXWS0n8vVnxEiwLN7h1Gj8vQIo4n4tRlUxE9E130_provenance.
- NP510313.RAGqlGGqmXWS0n8vVnxEiwLN7h1Gj8vQIo4n4tRlUxE9E130_assertion evidence source_evidence_literature NP510313.RAGqlGGqmXWS0n8vVnxEiwLN7h1Gj8vQIo4n4tRlUxE9E130_provenance.
- NP510313.RAGqlGGqmXWS0n8vVnxEiwLN7h1Gj8vQIo4n4tRlUxE9E130_assertion SIO_000772 18496132 NP510313.RAGqlGGqmXWS0n8vVnxEiwLN7h1Gj8vQIo4n4tRlUxE9E130_provenance.
- NP510313.RAGqlGGqmXWS0n8vVnxEiwLN7h1Gj8vQIo4n4tRlUxE9E130_assertion wasDerivedFrom befree-20140225 NP510313.RAGqlGGqmXWS0n8vVnxEiwLN7h1Gj8vQIo4n4tRlUxE9E130_provenance.
- NP510313.RAGqlGGqmXWS0n8vVnxEiwLN7h1Gj8vQIo4n4tRlUxE9E130_assertion wasGeneratedBy ECO_0000203 NP510313.RAGqlGGqmXWS0n8vVnxEiwLN7h1Gj8vQIo4n4tRlUxE9E130_provenance.